Stock HRMY HARMONY BIOSCIENCES HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Governance Harmony Biosciences Holdings, Inc.

Equities

HRMY

US4131971040

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 04:00:00 2025-01-10 pm EST 		5-day change 1st Jan Change
33.86 USD -1.94% Intraday chart for Harmony Biosciences Holdings, Inc. -2.65% -1.60%
Dec. 17 HC Wainwright Initiates Harmony Biosciences at Buy With $75 Price Target MT
Oct. 30 Harmony Biosciences Holdings Launches Secondary Common Stock Offering MT

Executive Committee: Harmony Biosciences Holdings, Inc.

Manager
Positions heldSince
Jeffrey Dayno

Jeffrey Dayno

67 year

Chief Executive Officer 2023-01-05
President 2023-01-05
David Bradshaw

David Bradshaw

63 year

Chief Tech/Sci/R&D Officer -
Luis Sanay

Luis Sanay

Investor Relations Contact 2022-02-28
Tricia Glover

Tricia Glover

Compliance Officer -
Sandipkumar S. Kapadia

Sandipkumar S. Kapadia

55 year

Chief Administrative Officer 2023-09-29
Director of Finance/CFO 2021-03-28
Audrey Murphy

Audrey Murphy

Human Resources Officer -
Ulrich Christian

Ulrich Christian

General Counsel 2020-12-31
Corporate Secretary -
Kumar Budur

Kumar Budur

54 year

Chief Tech/Sci/R&D Officer 2024-04-30

Composition of the Board of Directors: Harmony Biosciences Holdings, Inc.

Director
CommitteesSince
Jeffrey Aronin

Jeffrey Aronin

57 year

Chairman 2017-07-24
Gary Sender

Gary Sender

63 year

Audit Committee Chair 2021-09-07
Compensation Committee Chair 2021-09-07
Compensation Committee 2020-07-31
Juan Sabater

Juan Sabater

60 year

Governance Committee Chair
Nominating Committee Chair
Andreas Wicki

Andreas Wicki

65 year

Audit Committee
Compensation Committee
R. Graf

R. Graf

60 year

Audit Committee 2020-11-10
Finance Committee Chair
Linda Szyper

Linda Szyper

59 year

Governance Committee 2021-11-17
Nominating Committee 2021-11-17
Antonio Gracias

Antonio Gracias

54 year

Compensation Committee Chair
Peter Anastasiou

Peter Anastasiou

54 year

Compensation Committee 2023-11-04
Jeffrey Dayno

Jeffrey Dayno

67 year

Director/Board Member 2023-04-23

Latest Appointments: Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc. Announces Resignation of Jack Bech Nielsen from Board 24-07-01 CI
Harmony Biosciences Holdings, Inc. Appoints Kumar Budur as Executive Vice President and Chief Medical & Scientific Officer 24-05-03 CI
Harmony Biosciences Holdings, Inc. Appoints Peter Anastasiou as Class III Director and Member of the Compensation Committee of the Board 23-11-08 CI
Harmony Biosciences Holdings, Inc. Appoints Sandip Kapadia as Chief Administrative Officer 23-10-05 CI
Harmony Biosciences Holdings, Inc. Appoints Kumar Budur as Chief Medical Officer 23-05-02 CI
Harmony Biosciences Holdings, Inc. Appoints Jeffrey M. Dayno, M.D. as Chief Executive Officer 23-04-25 CI
Harmony Biosciences Holdings, Inc. Appoints Jeffrey M. Dayno, M.D. as President 23-04-25 CI
More news

Former Officers and Directors: Harmony Biosciences Holdings, Inc.

Insider
Positions held
SinceUntil
Jack Nielsen
Jack Nielsen
Director/Board Member 2017-08-31 2024-06-26
Independent Dir/Board Member 2017-08-31 2024-06-26
Sharon Goldbach
Sharon Goldbach
Corporate Officer/Principal - 2023-04-30
John Jacobs
John Jacobs
Director/Board Member 2018-05-31 2023-01-05
Chief Executive Officer 2018-05-31 2023-01-05
Corporate Officer/Principal 2017-09-30 2018-05-31
President 2018-05-31 2023-01-05
Eric L. Motley
Eric L. Motley
Director/Board Member 2020-11-10 2021-08-29
Independent Dir/Board Member 2020-11-10 2021-08-29
Susan Drexler
Susan Drexler
Director of Finance/CFO 2019-09-30 2021-03-28
Lisa M. Caperelli
Lisa M. Caperelli
Investor Relations Contact 2019-12-31 2020-12-31
Brian Yoor
Brian Yoor
Director/Board Member 2020-05-31 -
Independent Dir/Board Member 2020-05-31 -
Aaron Royston
Aaron Royston
Director/Board Member 2017-08-31 -
Martin Edwards
Martin Edwards
Director/Board Member 2017-07-31 -
Andrew Schiff
Andrew Schiff
Director/Board Member - -
Bill Gantz
Bill Gantz
Director/Board Member - -
Nancy Leone
Nancy Leone
Public Communications Contact - -

Age distribution of managers

Parity Men Women

Male 15
Female 4

Of which Executive Committee

Male 6
Female 2

Of which Directors

Male 8
Female 1
ESG MSCI
BB

ESG

Environment
Social
Governance
Controversy

Company Profile

Logo Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company. It is focused on developing and commercializing therapies for patients living with rare neurological diseases as well as patients living with other neurological diseases who have unmet medical needs. Its product, WAKIX (pitolisant), is a first-in-class molecule with a novel mechanism of action designed to enhance histamine signaling in the brain by binding to H3 receptors. Its WAKIX is developed for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy and treatment of cataplexy in adult patients with narcolepsy. It also provides HBS-102, an investigational compound, which is a melanin-concentrating hormone receptor 1 (MCHR1) antagonist that targets MCH neurons in the brain. It also develops ZYN002, a pharmaceutically manufactured synthetic cannabidiol. It is also focused on the rare epilepsy franchise in its expanding late-stage pipeline of CNS assets: EPX-100 and EPX-200.
Employees
246
Sector
Pharmaceuticals
Calendar
2025-01-15 - JP Morgan Healthcare Conference - Fireside Chat
More about the company

Departures of Key Persons

John Jacobs
-
John Jacobs

Chief Executive Officer

2018-05-31 2023-01-05

  1. Stock Market
  2. Equities
  3. HRMY Stock
  4. Company Harmony Biosciences Holdings, Inc.
  5. Governance